Source link : https://www.newshealth.biz/health-news/possible-pulmonary-benefit-with-viltolarsen-for-duchenne-muscular-dystrophy/
DENVER — Viltolarsen (Viltepso) was well tolerated by boys and men with Duchenne muscular dystrophy (DMD), with no new safety signals, according to results from the open-label, phase II Galactic53 trial. The results also suggested a clinical benefit in pulmonary function with the exon-skipping therapy, as measured by percent predicted forced vital capacity (FVC%p) and […]
Author : News Health
Publish date : 2024-04-16 18:59:30
Copyright for syndicated content belongs to the linked Source.